about
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?Sublingual apomorphine and Parkinson's diseasePen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.Subcutaneous apomorphine in the treatment of Parkinson's disease.Comparison of motor response to apomorphine and levodopa in Parkinson's disease.What the future holds for deep brain stimulation.The modern management of Parkinson's disease.Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.Apomorphine hydrochloride for the treatment of Parkinson's disease.Advanced stages of PD: interventional therapies and related patient-centered care.Apomorphine for motor fluctuations and freezing in Parkinson's disease.Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.
P2860
Q28366409-AC7E66A1-817F-45A5-9187-9223BEE3624AQ33627530-6DCB9317-0403-492A-A780-992B4D819FC8Q33734263-175F852C-D356-47EE-8AD3-ACDB7AB327E4Q36318159-A615A367-A9CA-49D7-BC93-F1F9005357D3Q36319026-A9F25B6B-85B8-403F-9828-26916C8892EDQ36484966-5927399F-7469-4948-92CB-8399C74CDAC1Q36933519-EE987C66-B7F8-4045-8AA8-1AC2DAB22DF6Q36942130-49B6CC7C-3BFF-44AF-8ABA-8ACBE10D7B0BQ37013009-39B20944-0DD5-425B-A367-E8E2CB843EDFQ37809006-F8D7B81C-8E7B-46D4-A64C-BA72E1D3DD9CQ38155589-91601B45-73C1-4117-9AF8-438BCC940D4FQ38513905-F1CAA4FD-0BE1-4EBC-928C-577A9EA94419Q38542180-365FD340-694F-4D64-8CD7-3CEA30F0D904Q40441758-57F59678-867E-444A-91FF-4343177F56CFQ42164149-59113440-B701-4E83-8489-BD5F95C737DBQ47868277-D036CCDA-8220-4F98-AB9F-A35615503A30
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Subcutaneous apomorphine in Parkinson's disease.
@en
type
label
Subcutaneous apomorphine in Parkinson's disease.
@en
prefLabel
Subcutaneous apomorphine in Parkinson's disease.
@en
P2093
P356
P1476
Subcutaneous apomorphine in Parkinson's disease.
@en
P2093
P2860
P356
10.1136/JNNP.52.4.544
P407
P577
1989-04-01T00:00:00Z